Apoha emerges from stealth with $36M in total funding
Apoha’s launch brought its molecular-behaviour measurement technology into public view, with Singular leading the reported investment backing.
The June announcement named Draper Associates alongside returning investors Redalpine, Seedcamp, Wilbe and Nucleus, and separately described Innovate UK grant support. Apoha’s own website characterizes $36 million as total funding, so that figure is not recorded here as a disclosed new equity-round amount.
Founded in 2021 by Shamit Shrivastava and Anshika Srivastava, the company is commercializing research into how molecular systems respond to physical stress. Its launch highlighted work with pharmaceutical and other industrial partners as it moved beyond stealth.
Use of funds
Commercialize molecular-behaviour measurement technology